fda compounding semaglutide news Popular diabetes drug is a 'good story.' Here's why consumers need to proceed with caution Fifth Circuit probes FDA ban

(2020): Beneficial effects of l-carnitine supplementation for weight management in overweight and obese adults: An updated systematic review and dose-response meta-analysis of randomized controlled trials

On December 22, 2025, the FDA approved Novo Nordisk's once-daily oral semaglutide (Wegovy pill, 25 mg) for chronic weight management and cardiovascular risk reduction (FDA / Novo Nordisk, 2025)

So, Mikhail Kapchits, MD, our board-certified cardiologist at Advanced Medical Care, is here to explain how to recognize different types of angina and what to do if you experience it

Activates parasympathetic nervous system, reduces nausea